UBS Group’s Inovalon Holdings, Inc. Class A Common Stock INOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-978,386
| Closed | -$39.4M | – | 11325 |
|
|
2021
Q3 | $39.4M | Buy |
978,386
+927,109
| +1,808% | +$35M | 0.01% | 1011 |
|
|
2021
Q2 | $1.75M | Buy |
51,277
+12,946
| +34% | +$400K | ﹤0.01% | 3704 |
|
|
2021
Q1 | $1.1M | Sell |
38,331
-69,784
| -65% | -$1.79M | ﹤0.01% | 4158 |
|
|
2020
Q4 | $1.96M | Buy |
108,115
+51,957
| +93% | +$1.11M | ﹤0.01% | 3428 |
|
|
2020
Q3 | $1.49M | Buy |
56,158
+54,133
| +2,673% | +$1.27M | ﹤0.01% | 3340 |
|
|
2020
Q2 | $39K | Sell |
2,025
-8,054
| -80% | -$143K | ﹤0.01% | 6087 |
|
|
2020
Q1 | $168K | Sell |
10,079
-87,578
| -90% | -$1.66M | ﹤0.01% | 4861 |
|
|
2019
Q4 | $1.84M | Buy |
97,657
+37,244
| +62% | +$623K | ﹤0.01% | 3642 |
|
|
2019
Q3 | $990K | Buy |
60,413
+40,827
| +208% | +$652K | ﹤0.01% | 3976 |
|
|
2019
Q2 | $284K | Buy |
19,586
+18,271
| +1,389% | +$248K | ﹤0.01% | 4686 |
|
|
2019
Q1 | $16K | Sell |
1,315
-34,039
| -96% | -$461K | ﹤0.01% | 6519 |
|
|
2018
Q4 | $501K | Buy |
35,354
+2,307
| +7% | +$26.3K | ﹤0.01% | 4266 |
|
|
2018
Q3 | $332K | Buy |
33,047
+13,614
| +70% | +$148K | ﹤0.01% | 4689 |
|
|
2018
Q2 | $193K | Buy |
19,433
+5,637
| +41% | +$58.3K | ﹤0.01% | 4968 |
|
|
2018
Q1 | $146K | Sell |
13,796
-7,808
| -36% | -$97.8K | ﹤0.01% | 4983 |
|
|
2017
Q4 | $324K | Buy |
21,604
+6,704
| +45% | +$107K | ﹤0.01% | 4590 |
|
|
2017
Q3 | $254K | Buy |
14,900
+6,449
| +76% | +$90.3K | ﹤0.01% | 4688 |
|
|
2017
Q2 | $111K | Sell |
8,451
-19,403
| -70% | -$252K | ﹤0.01% | 5100 |
|
|
2017
Q1 | $351K | Sell |
27,854
-54,064
| -66% | -$626K | ﹤0.01% | 4281 |
|
|
2016
Q4 | $843K | Sell |
81,918
-49,045
| -37% | -$669K | ﹤0.01% | 3688 |
|
|
2016
Q3 | $1.93M | Buy |
130,963
+52,034
| +66% | +$864K | ﹤0.01% | 2880 |
|
|
2016
Q2 | $1.42M | Buy |
78,929
+74,726
| +1,778% | +$1.34M | ﹤0.01% | 3071 |
|
|
2016
Q1 | $78K | Sell |
4,203
-1,702
| -29% | -$30K | ﹤0.01% | 5160 |
|
|
2015
Q4 | $101K | Buy |
5,905
+1,436
| +32% | +$28.5K | ﹤0.01% | 5199 |
|
|
2015
Q3 | $93K | Sell |
4,469
-5,025
| -53% | -$117K | ﹤0.01% | 5295 |
|
|
2015
Q2 | $265K | Buy |
9,494
+5,377
| +131% | +$144K | ﹤0.01% | 4634 |
|
|
2015
Q1 | $125K | Buy |
+4,117
| New | +$123K | ﹤0.01% | 5251 |
|
UBS Group's INOV Position: Q4 2021 in Review
UBS Group sold out of Inovalon Holdings, Inc. Class A Common Stock (INOV) in Q4 2021, closing a stake of 978,386 shares — an estimated $39.4M sold.
UBS Group first reported a position in INOV in Q1 2015 and held it in 27 quarters. The position peaked at $39.4M in Q3 2021. 0 funds tracked by Wall St. Rank hold INOV as of Q4 2021.
- UBS Group reported no remaining Inovalon Holdings, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
- UBS Group sold 978,386 Inovalon Holdings, Inc. Class A Common Stock shares in Q4 2021, an estimated $39.4M.
- UBS Group first reported a position in Inovalon Holdings, Inc. Class A Common Stock in Q1 2015 and held it in 27 quarters.
- UBS Group's Inovalon Holdings, Inc. Class A Common Stock position peaked at $39.4M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Inovalon Holdings, Inc. Class A Common Stock as of Q4 2021.
Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.